QXO, Inc. (NYSE: QXO) — A Leveraged Bet on Brad Jacobs, Fully Priced and Falling

Independent fundamental research. Report date: 2026-07-02. As-of price: $16.21 (QXO close, 2026-07-02). Company completed its ~$17B acquisition of TopBuild Corp. on ~July 1, 2026 — one day before this report; all figures are pro-forma where noted.

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The analysis that follows it is deliberately position-free and carries no price target.

Verdict: HOLD / speculative-accumulate-on-weakness / NOT-a-short. Conviction: LOW-to-MEDIUM. This is not a value stock, not a proven compounder, and not a momentum name — it is a leveraged call option on Brad Jacobs’ sixth roll-up, priced at a full multiple with a falling-knife tape. Directional fair-value zone: on base-case ~$2.4–2.6B adjusted EBITDA at ~11–12x against ~$8B net debt and a ~$4B convertible-preferred stack, per-share intrinsic value sits roughly in line with spot — a ~$14–22 zone — with a fat left tail (leverage amplifies any operational miss) and a long right tail (the “$50 billion platform” option). I would own it only as a small, option-sized position, and I would rather establish it in the low-teens/high-single-digits, where the asset-value floor (strategics are paying 11–13.5x to enter this channel) gives more cushion than the multiple does.

The tension is real and unusually clean. On one side: Jacobs’ track record is genuinely elite — five prior multi-billion-dollar companies (United Waste, United Rentals, United Grinding, and XPO, which he built by aggregation and then unlocked by spinning out GXO and RXO). Few operators create value through both assembly and disassembly. On the other side: you are paying top dollar for the privilege. QXO deployed ~$30B in ~15 months (Beacon ~$10.8B, Kodiak ~$2.25B, TopBuild ~$17B at 14.9x — the high end of the entire space, at a soft point in the housing/repair-remodel cycle); the combined company is GAAP-loss-making by construction (−$851M/−$0.79 to common pro-forma, even in a normalized year, under $1.22B of amortization + $496M interest + $264M preferred dividends); tangible common equity is deeply negative; the true fully-diluted share count is ~1.7 billion, not the 725M common (219M in-the-money warrants + three preferred series); and leverage jumps from ~0x to ~3.8x (≈5.2x including the $2.94B Apollo Series C) the moment TopBuild closes. There is no structural moat — local branch density is real but matched by ABC Supply and Home Depot-owned SRS+GMS — so the “tech-enabled distribution” edge is an unproven hypothesis, and Q1-2026 combined adjusted EBITDA was $1.2 million. The framing is a de-rated, idiosyncratic special situation (factor model barely fits, R²~5%; negative Sharpe on every real horizon; price below all moving averages; ~30–35% off the January/April highs and ~29% below the deal-signing level). The market is voting skeptical, and the acquirer’s own falling stock has already stripped ~$80/share of consideration from TopBuild holders via the no-collar exchange ratio.

Why HOLD and not a short: the deal has closed, the break risk is gone, Jacobs is not going to stop, the asset value floors the pieces, and shorting a levered dealmaker at the start of his playbook — after a 35% de-rating — is asymmetric the wrong way. Why not a table-pounding buy: there is no margin of safety in the multiple, the cash economics are roughly half the adjusted headline, and the whole thesis rests on one operator executing a triple-integration into a soft cycle with a stacked, dilutive balance sheet.

Framing / catchy tag: “Betting the jockey at the top of his own auction.” What flips me bullish: two-to-three quarters of proof — combined adjusted-EBITDA margin expanding toward the low-teens with organic volumes inflecting positive and net leverage falling below 3x (the transformation showing up in the numbers, not the slides). What flips me bearish: a deepening housing/R&R downturn with EBITDA stalling near ~$2B while the fixed-charge stack bites, a botched integration, or yet another richly-priced, dilutive megadeal before the current three are digested.

📈 Stock Price Action — Five-Year Event Map

Factual price history, not a recommendation. Prices are FACT (daily price data, unadjusted = real traded price); attributed drivers are INTERPRETATION.

QXO barely has a five-year price history worth reading, and that is itself the point. Before December 2023 the ticker was SilverSun Technologies, an illiquid ~$3 software/IT-VAR penny-shell irrelevant to today’s company (the source of the stale “software/technology/consulting” description and the −96% five-year drawdown that still pollute third-party data feeds — disregard both). The real company began when Brad Jacobs took control in December 2023 and recapitalized the shell into a building-products roll-up vehicle. Clean, liquid trading effectively starts around August 2024. From there the arc is: thin-float hype → recapitalization reset → a run to the low-$20s as Beacon and Kodiak closed → a ~30–35% de-rating on the TopBuild megadeal. Today’s $16.21 sits ~30–35% below the ~$25–26 January/April-2026 highs, inside a ~$13–26 52-week range, below its 21-, 50- and 200-day moving averages.

Cycle narrative. Events 0–2 are a shell being recapitalized into a vehicle — noise, not fundamentals. Events 3–5 are the market rewarding the first real platform (Beacon) and the operating-company re-rate, tempered by the June-2025 signal that a deeper-pocketed strategic (Home Depot/SRS) could outbid QXO for GMS. Event 6 is the roll-up machine at full speed (Kodiak + a $3B preterred commitment) driving the stock to its cycle high. Events 7–8 are the critical, non-obvious ones: the stock has fallen ~30–35% not on any operating disaster but because the market re-priced the risk of paying 14.9x for TopBuild at a housing trough, funded with ~$8B of net debt and heavy dilution — and because the fixed 20.2x no-collar exchange ratio mechanically dragged the whole package down as QXO’s own equity slid. The price you see today is the market’s skeptical verdict on the megadeal, not a fundamental break in the business.

1. Executive Summary

QXO, Inc. is Brad Jacobs’ sixth roll-up — an attempt to consolidate the ~$800B North American building-products distribution industry (and, as of July 1, 2026, installation) into a $50-billion-revenue platform “within the decade.” In roughly fifteen months, Jacobs took a defunct software shell, injected ~$1B, raised more than $15B of equity and ~$9B of debt/preferred, and bought three businesses: Beacon Roofing Supply (~$10.8B, the #1/#2 US roofing distributor, closed April 2025), Kodiak Building Partners (~$2.25B, a lumber/building-materials distributor, closed April 2026), and TopBuild Corp. (~$17B, the #1 US insulation installer and specialty distributor, closed July 1, 2026). The result is the second-largest publicly traded building-products distributor in North America: pro-forma ~$17–18B revenue and ~$2.0–2.2B adjusted EBITDA.

The investment question is not really about roofing or insulation. It is about whether you want to underwrite Jacobs — a genuinely elite capital allocator — at this price, on this balance sheet, at this point in the cycle. The bull case is the man’s record and a fragmented, R&R-anchored industry with a long consolidation runway. The bear case is everything the roll-up currently is: a business with no durable structural moat (local branch density is real but matched by private ABC Supply and Home Depot-backed SRS+GMS); GAAP losses by construction for years to come (−$851M to common pro-forma, even normalized, under $1.22B amortization + $496M interest + $264M preferred dividends); deeply negative tangible common equity; a ~1.7-billion fully-diluted share count masked by a 725M common figure; and ~3.8x net leverage (≈5.2x including the Apollo Series C preferred) into a soft, rate-sensitive housing market. Combined adjusted EBITDA in the seasonally weak Q1-2026 was $1.2 million.

On valuation, the combined enterprise value of ~$28–31B against ~$2.1B run-rate adjusted EBITDA is ~13–15x pre-synergy (~11–12x post the targeted $300M of synergies) — the high end of the distribution-peer range (BLDR ~10x, SITE ~12x, FERG ~14x), and roughly what QXO paid for the assets. There is no valuation discount here; you pay a full price for the roll-up option. The equity has de-rated ~30–35% since the TopBuild signing and trades below every moving average with negative risk-adjusted returns on every horizon — the market is voting skeptical. The margin of safety, if any, is asset value (strategics pay 11–13.5x to enter this channel), not the multiple. This report takes no position; it lays out the mechanism, the numbers, and the disconfirming evidence on each side.

2. Business Overview

What QXO is. As of July 1, 2026, QXO is a North American building-products distribution-and-installation platform assembled from three acquisitions in fifteen months. It reaches contractors and builders through three engines:

• QXO Building Products (formerly Beacon Roofing Supply) — the anchor, closed April 29, 2025. The largest publicly traded distributor of roofing, waterproofing and complementary building products in North America: ~600 branches across all 50 US states and 7 Canadian provinces, serving >110,000 residential and non-residential customers, with a 95-year operating history. This is the business behind essentially all of FY2025’s reported revenue.
• Kodiak Building Partners — ~$2.25B, closed April 1, 2026. A lumber and building-materials (LBM) distributor (~$2.4B revenue, ~$211M EBITDA), heavily weighted to Florida and Texas, adding lumber, millwork, gypsum and related categories.
• TopBuild Corp. (TruTeam + Service Partners) — ~$17B, closed July 1, 2026. The #1 US installer of insulation (TruTeam, ~59% of TopBuild sales, >200 branches, crews paid substantially on piecework) and the #1 pure specialty distributor of insulation/accessories (Service Partners, ~41%, >250 distribution centers). FY2025 revenue ~$5.4B, adjusted EBITDA ~$1.04–1.14B at an ~18–19% margin — far above distribution economics because installation sells installed labor plus materials.

Revenue segmentation. FY2025 net sales of $6,842.2M (nine months of Beacon plus de-minimis legacy software) split by line of business: residential roofing 48.3% ($3,307M), non-residential roofing 27.5% ($1,884M), complementary building products 23.3% ($1,593M, i.e., siding, waterproofing, plywood/OSB, windows and doors), and legacy software 0.9%. ~98% of sales are US, ~2% Canada. Customer concentration is negligible — no single customer exceeded 1% of net sales. The private-label brand is TRI-BUILT (higher-margin, brand-exclusive). Largest suppliers are the roofing majors: Owens Corning, GAF, Carlisle, CertainTeed, IKO, TAMKO, Johns Manville, James Hardie.

How it makes money. Value-added distribution: QXO buys from a concentrated set of manufacturers and resells to a fragmented base of local, regional and national contractors, capturing a gross-margin spread (~23–25%) for job-specific product bundling, product advice, last-mile delivery/logistics and trade credit. It converts a low-teens-to-mid-single-digit EBITDA margin (distribution) blended up by TopBuild’s high-teens installation margin. Roofing distribution is structurally attractive within the space because it is ~80% repair-and-replacement, of which ~94% is non-discretionary (leaks, age, storm damage) — a defensive annuity that distinguishes QXO from pure new-construction distributors. Insulation is code-required and non-deferrable but more single-family-starts-levered; LBM (Kodiak) is the most cyclical leg.

Recurring vs. cyclical. The revenue base is bimodal: roughly half is defensive (Beacon re-roofing + TopBuild’s counter-cyclical distribution channel and code-required insulation), and roughly half is cyclical (new residential and non-residential construction, LBM). None of it is contractually recurring, but the R&R roofing annuity is the closest thing to it.

The “tech-enabled” overlay. Management’s stated differentiator is a “tech-enabled” transformation — AI-assisted pricing, predictive inventory, route optimization, private-label penetration, e-commerce and zero-based budgeting — layered onto acquired branches. This is the explicit value thesis. As of today it reads as operational self-help and table stakes rather than a proven edge: FY2025 adjusted EBITDA margin (9.5%) was below Beacon’s standalone ~10–11% because transformation and restructuring spend lands before the benefits.

Verdict. A real, large, cash-generative distribution platform with a defensive core (R&R roofing) bolted to cyclical legs (insulation installation, LBM) and, now, a genuine business-model addition — labor-based installation via TopBuild. The scale is real; the revenue quality is bimodal; the “tech” premium is unproven.

3. Industry Dynamics

Structure and size. Building-products distribution is a ~$800B global market (roughly split North America / Western Europe), and it is highly fragmented — QXO cites >7,000 North American distributors, with ~30% of roofing volume still served by 500+ local dealers. That fragmentation is the entire strategic premise: a long runway to consolidate a tail of sub-scale, family-owned distributors. QXO’s core served market is roughly $65B (roofing ~$37B growing 3–5%; complementary ~$28B growing 4–6%), and management frames the combined addressable market at “>$200B” once insulation and LBM are included.

Profit pools and returns. The catch is that distribution is structurally a thin-margin, capital-cyclical business. Through-cycle EBITDA margins run ~8–12% for roofing/LBM distributors and only reach the high-teens in the labor-levered installation niche (TopBuild). Returns on capital swing violently with the housing cycle — peer Builders FirstSource earned 32–35% ROIC at the 2021–22 peak and ~7% at the trough. This is not a business with a stable, high, protected return; it is a cyclical, competitive, scale-and-density game.

Demand drivers. Three, with very different cyclicality: (1) residential repair-and-remodel / re-roofing — the defensive anchor (~80% of roofing demand, ~94% non-discretionary, storm-frequency-aided); (2) new residential construction — rate-sensitive and currently soft (single-family starts ran ~941k in 2025, ~17% below the 2021 peak, gated by ~6.5–7% mortgage rates); (3) non-residential construction — its own slower cycle, with a secular offset in data-center/industrial mechanical insulation via TopBuild. The current environment is unambiguously soft: TopBuild’s Q1-2026 installation organic volume fell −9.8% with pricing −2.9%, and Beacon’s organic volumes were down year-on-year.

Competitive intensity and the capital cycle (Marathon lens). This is the single most important structural fact, and it cuts against QXO’s returns. Over 2024–2026, more than $40B of strategic capital flooded the channel: Home Depot bought SRS Distribution (~$18B, 2024) and then GMS (~$5.5B, 2025); Lowe’s bought Foundation Building Materials (~$8.8B) and installer Artisan Design Group (~$1.3B); and QXO itself poured in ~$30B (Beacon + Kodiak + TopBuild). Marathon’s capital-cycle framework is explicit about what follows: the super-normal returns of the 2021–22 housing boom attracted this capital, and better-capitalized strategics now (a) compete away pricing and (b) bid up the very tuck-in multiples that fuel a roll-up. QXO’s own aggressive issuance-funded M&A is part of the flood — a textbook asset-growth-anomaly setup that historically predicts lower forward returns. The partial offset: as weak private distributors are squeezed, organic share migrates to the scaled survivors, and strategics’ 11–13.5x entry multiples put a floor under QXO’s asset value.

Regulation. Light-touch — no rate regulation, no reimbursement, no licensing chokepoint. Building codes (energy-efficiency insulation requirements) are a modest secular tailwind for TopBuild; tariffs on steel/aluminum and lumber-price volatility are periodic input-cost swing factors.

Verdict: structurally MIXED — attractive for a disciplined consolidator, but the capital cycle has turned against returns. Genuine fragmentation and a defensive R&R core make this a good hunting ground for a roll-up. But thin through-cycle margins, violent cyclicality, and — critically — the recent flood of deep-pocketed strategic capital cap both pricing power and M&A-multiple upside. This is a good-not-great industry, and it just got more crowded at exactly the moment QXO scaled into it.

4. Competitive Position

The moat, named (Greenwald taxonomy): local economies of scale + branch/route density + moderate customer captivity — defensible MSA-by-MSA, not nationally. In distribution, the only durable advantage is local: in a given metro, the distributor with the densest branch network and the most trucks can offer faster fill rates, more SKUs in stock, and lower delivery cost per drop than a sub-scale local rival — and contractors, who value on-time job-site delivery above almost everything, are moderately captive once a branch knows their business. This is a real advantage, and Beacon has it in many markets. But it is won and defended one metro at a time, and it does not aggregate into a national moat.

Why the national “scale” claim is weak. QXO’s pitch leans on national purchasing scale and “tech-enablement.” Both are size, not scale:

• Purchasing power at $17–18B of revenue is real but matched or exceeded by private ABC Supply (larger, disciplined, ~$20B+ revenue) and by Home Depot-owned SRS+GMS (backed by a $350B+ balance sheet). QXO does not buy shingles materially cheaper than its two largest competitors.
• Tech-enablement is table stakes. Home Depot and SRS have equal-or-greater technology resources; AI pricing and route optimization are cost levers any scaled competitor can and will deploy. The XPO precedent is instructive: Jacobs’ pricing/tech tools there were genuinely effective cost levers, yet XPO still earns only ~9% ROIC and “most of the moat it benefits from is the oligopoly’s, not XPO-specific.” Technology lowered cost; it did not create a barrier.

The share-stability and ROIC tests. QXO fails the Greenwald market-share-stability test at the national level — its share was bought, not won, and would not be stable absent continued M&A. It passes only locally, where density is genuine. On ROIC, distribution returns are cyclical and unremarkable (peer range 7% trough to low-30s peak), and QXO’s own tangible-capital base is negative — the returns live in goodwill.

Direct competitive read. QXO is not advantaged versus its two most important rivals. ABC Supply (private, patient, no public-market dilution pressure) and SRS+GMS (Home Depot’s capital, distribution reach and Pro ecosystem) both have equal-or-greater density and materially deeper pockets. The June-2025 episode is the tell: QXO lost GMS to Home Depot/SRS — direct evidence that a scaled strategic can and will outbid it for the best assets. There is no brand moat (contractors buy on availability, price and relationship, not distributor brand) and no network effect. Contractor switching costs are moderate — most buy from multiple distributors and can re-source — so TRI-BUILT private label is a margin lever, not a lock-in.

The real “moat” is the jockey. The strongest argument for QXO is not structural; it is Brad Jacobs’ capital-allocation record — five prior multi-billion-dollar roll-ups, and the rare feat of creating value through both aggregation (building XPO) and disaggregation (spinning GXO and RXO). That is a genuine, if unusual, asset. But it is management quality and operational effectiveness, not a Greenwald structural barrier — and it is subject to three hard limits the 10-K itself flags as risk factors: it is key-person-dependent (the filing explicitly lists “dependence on Brad Jacobs,” who is 69, and “past performance may not be representative of future results”); it is leverage-amplified (the playbook now runs on ~$8B of debt plus a ~$4B preferred stack); and it is being executed on three simultaneous integrations at a cyclical-volume low.

Verdict: NO durable independent moat — a leveraged bet on an operator in a good-but-competitive, newly-crowded industry. The local density is real and defensible metro-by-metro, but it is matched by ABC Supply and out-resourced by Home Depot’s SRS+GMS, and the “tech-enabled” edge is unproven and imitable. What you are underwriting is the jockey, not a structural fortress.

5. Growth History and Forward Opportunities

History — essentially 100% acquired, with a soft organic core. QXO has no meaningful organic operating history: the entire reported revenue base was purchased. Underneath, the acquired businesses’ organic trajectories are negative — Beacon’s standalone volumes ran down ~3–4% per day in its last independent quarters (growth carried entirely by its own bolt-on program), and TopBuild is guiding volume and price down into 2026. The reported revenue trajectory (from $57M in FY2024 to $6.84B in FY2025 to a >$17B pro-forma run-rate) is a deal-driven step-function, not organic compounding.

Forward — the runway is genuine, but so is the dilution. The bull case is a long inorganic runway plus a margin-transformation option:

• Inorganic. A fragmented >$200B addressable market and ~$3B of Apollo Series C preferred as deal dry-powder give Jacobs the means to keep buying toward the “$50B revenue within a decade” target he reaffirmed as recently as May 2026 (“We remain firmly on track…”). Likely future platforms extend into adjacent distribution categories (plumbing, HVAC, electrical, waterworks) where the same fragmentation exists. Every deal, however, is funded with dilutive equity/preferred and incremental debt — and the GMS loss shows QXO does not always win.
• Organic / margin transformation. The higher-quality growth thesis is margin, not volume: digital penetration (~16% of Beacon sales, at +150–200bps of margin), private-label mix (+500–2000bps on TRI-BUILT SKUs), procurement scale, and cross-selling across a common ERP. This is credible and is where a real edge could emerge — but it is entirely unproven at QXO, and the current combined adjusted-EBITDA margin (Q1-2026: 0.1%) proves nothing yet.

Quality of growth. For now, high-quantity, unproven-quality — levered roll-up bulk. The company is buying revenue and EBITDA with issued paper and debt; whether that becomes high-quality growth depends on the margin-transformation thesis landing and the cycle turning. It is a bet on future quality, not evidence of present quality.

Verdict. The runway is real and the ambition is credible given the operator; but the growth to date is acquired bulk into a soft cycle, the organic core is shrinking, and the transformation that would make the growth high-quality is a hypothesis with no QXO track record. Gate the growth verdict on integration execution plus a cycle turn.

6. Financial Quality

This is the section where QXO’s numbers most demand a skeptic’s eye, because the reported GAAP results and the “adjusted” results tell almost opposite stories, and both are true.

GAAP: loss-making, by construction. FY2025 (nine months of Beacon): net sales $6,842.2M, GAAP gross profit $1,572.7M (23.0% margin), GAAP operating loss −$245.2M, net loss −$279.4M, and net loss to common −$388.3M (−$0.63/sh) after $108.9M of preferred dividends. On a pro-forma basis (all three deals as if owned for a full FY2025), the S-4 shows net sales of $17,283.7M but a net loss to common of −$851.2M (−$0.79/sh) — even in a normalized year — because roughly $2.0B of below-the-line charges ($1,217.6M of PPA amortization + $496.3M of interest + $264.1M of preferred dividends) sit underneath ~$2B of adjusted EBITDA. This is the central quality-of-earnings fact: the combined company will report GAAP losses to common for years regardless of operating performance, so any headline “P/E” is meaningless and the equity trades on Adjusted EBITDA / Adjusted EPS alone.

The adjusted bridge, and how much to trust it. Management bridges the FY2025 net loss of −$279.4M to Adjusted EBITDA of $647.8M (9.5% margin) by adding back depreciation ($108.4M), amortization ($314.7M, largely PPA customer-relationships/tradenames), SBC ($144.5M), net interest ($47.7M), a debt-extinguishment loss ($49.7M), restructuring ($59.6M), transaction costs ($83.7M), transformation costs ($44.9M) and a $131.7M inventory fair-value step-up, net of tax. Adjusted net income was $362.7M and Adjusted diluted EPS $0.34. A skeptic should discount this in three ways: (1) SBC of $144.5M is 22% of adjusted EBITDA — real, recurring dilution added back; (2) the $188.2M of “non-recurring” transaction + transformation + restructuring costs recur for a serial acquirer (every deal generates them); and (3) the inventory step-up is genuinely non-cash but will repeat (~$130M+ on TopBuild in 2026). Keeping SBC and recurring deal costs, a “clean” cash EBITDA is roughly half the $647.8M headline. The adjusted number is directionally the right lens for a roll-up, but it flatters the real cash economics.

Free cash flow and working capital. FY2025 operating cash flow was $261.4M and capex ~$74M, so true free cash flow was ~$190M — note that ROIC’s reported “free cash flow” of $261.4M omits capex and overstates it. Working capital is violently seasonal — Q2-2025 OCF was −$174.2M as receivables built +$656.5M into the spring ramp, then reversed in H2 — so no single quarter can be annualized. Q1 is seasonally loss-making (winter); Q1-2026 consolidated adjusted EBITDA was $1.2M on $1,730M of sales, with a net loss of −$227M. Distribution is a working-capital-intensive business (inventory $1.67B, receivables $1.65B at Q1-2026), and cash generation is back-half-weighted.

Balance sheet and returns. Pro-forma, goodwill ($15.3B) plus intangibles ($10.9B) equal $26.2B, or 75% of $34.9B total assets — so tangible common equity is deeply negative and any ROE/ROIC computed on GAAP equity is meaningless. The economically relevant return question is whether incremental branches and acquired businesses earn above the ~5.5% blended cost of the debt plus the preferred coupons — and the honest answer is unproven, dependent on the transformation and the cycle. Distribution adjusted-EBITDA margins of ~9.5–12% are decent, not exceptional; TopBuild’s ~18% installation margin is the profit engine that lifts the blend.

Verdict: a real ~$2B-adjusted-EBITDA business with LOW GAAP earnings quality and MODERATE adjusted quality. Economics could improve with scale if procurement/pricing synergies and the cycle deliver — but that is a hypothesis, not a demonstrated trend, and a meaningful share of the adjusted add-backs (SBC, recurring deal costs) are economically real. The cash the business actually generates today (~$190M FY2025 FCF, scaling) is modest against a ~$28–31B enterprise value.

7. Capital Allocation

Capital allocation is the thesis at a Jacobs vehicle, so this section carries unusual weight.

The playbook, at extraordinary speed and scale. In ~15 months QXO deployed ~$30B across three acquisitions — Beacon (~$10.79B), Kodiak (~$2.25B), TopBuild (~$17B) — funded by an escalating series of equity raises (from $9.14 to $23.80 per share), three preferred series, and ~$9B of debt. This is the Jacobs method compressed into record time: raise a war chest against a credible-operator narrative, buy an anchor, then compound via bolt-ons and a second and third platform.

Prices paid — fair to full. Beacon at ~11–12x its ~$0.9–1.0B EBITDA was a reasonable price for the #1 US roofing distributor. TopBuild at 14.9x LTM EBITDA (11.8x only on 2030 synergies) was a full price — the high end of the entire space — paid at a soft point in the housing cycle, with TopBuild’s own organic volumes already negative. The “cheap” 11.8x rests on $300M of synergies that phase in only by 2030. Paying the top multiple for the best asset at a cyclical low is defensible if you believe in the platform and the operator, but it is the opposite of the distressed, below-replacement-cost buying (e.g., XPO’s Yellow terminals) that marked Jacobs’ best historical deals.

Funding — dilutive, and issuing an undervalued currency. The TopBuild consideration of $505/share (45% cash / 55% stock at a fixed 20.2x ratio) implied a $25.00 QXO reference price; with QXO now ~$16, QXO is issuing ~311M shares of an undervalued currency and stock-electing TopBuild holders are receiving ~$327 of value (underwater). The stock trades below every 2025/26 primary raise except the very first ($9.14) — the market is repeatedly declining to validate the escalating issuance prices. Pro-forma leverage steps from ~0x to ~3.8x net (≈5.2x including the $2.94B Apollo Series C), and the deleveraging thesis rests on the same unproven synergies and cycle recovery.

Alignment — structural, but no conviction buying. Jacobs is genuinely aligned in structure: Jacobs Private Equity II holds 900,000 of the 1.0M Convertible Perpetual Preferred shares — ~197M as-converted common, ~$0.9–1.0B of personal capital at a $4.566 conversion price — plus a share of the 219M warrants. But that capital went in at the bottom of the structure on preferred terms, not via open-market common purchases: there are zero code-P open-market insider buys in the QXO era (recent Form 4s are grants, option exercises and tax-withholding sales). And the incentive design is a Marathon-style demerit: executive PSUs vest on relative TSR versus the S&P 500 with no ROIC or return-on-capital metric — and Jacobs’ initial-period PSUs certified at 225% of target (maximum) through December 2025, i.e., paid out at the cap on a stock that has since fallen. Management is paid to grow and to beat the index, not to earn a return on the ~$30B of capital consumed.

No buybacks, no dividend. All capital goes to M&A — consistent with the playbook and appropriate for the stage, but it means shareholders get no capital return and bear full dilution.

Verdict: the Jacobs playbook executed fast and at scale on an expensive, dilutive, heavily-levered capital structure — with genuine sponsor alignment but the wrong incentive metric and no open-market conviction buying. Whether this creates or destroys value hinges entirely on synergy execution and the housing/R&R cycle. Prices paid were fair (Beacon) to full (TopBuild); the funding issues undervalued equity; and the comp plan rewards size and relative TSR, not economic return. Empire-building risk is high, and the market is currently skeptical.

8. Changes and Headwinds — Last Two Years

QXO is unusual in that the company is the change — there is no legacy business to compare against. The two-year timeline:

• Dec 2023: Jacobs takes control of the SilverSun shell (~$1B injection); renames it QXO; declares the building-products roll-up strategy.
• 2024: ~$5B+ of equity raises (from ~$9.14/share) plus the Convertible Perpetual Preferred and 219M warrants build the war chest; NYSE relisting.
• Nov 2024–Apr 2025: Beacon Roofing tender ($124.25→$124.35/share), which went hostile before the board agreed; closed April 29, 2025 — the first operating platform.
• ~Jun 2025: QXO loses GMS to Home Depot/SRS — a direct signal that a deeper-pocketed strategic can outbid it for premier assets.
• Jan–Apr 2026: Apollo-led Series C convertible preferred (~$3B commitment); Kodiak (~$2.25B, closed April 1) adds LBM.
• Apr–Jul 2026: TopBuild (~$17B) announced April 20, approved by both shareholder bases June 29, closed July 1, 2026 — adding insulation installation and pushing the platform to >$17B revenue.
• Leadership: Jacobs staffed QXO with former XPO/United Rentals executives; new insiders onboarded post-TopBuild (July 1–2, 2026 Form 3/4 filings).

Headwinds. (1) Soft, rate-sensitive end markets — single-family starts ~17% below peak, TopBuild installation organic volume −9.8% in Q1-2026, Beacon volumes down. (2) Business-model drift into installation/labor — TopBuild adds piecework crews and project-execution risk, a departure from pure distribution. (3) Simultaneous triple-integration risk — Beacon, Kodiak and TopBuild all being digested at once. (4) A stacked, dilutive capital structure — ~$8B net debt plus ~$4B of preferred, ~$6B of it floating-rate. (5) Litigation noise — routine merger-objection suits. (6) Sell-side de-rating — KeyBanc cut its price target from $32 to $28 on July 1.

Verdict: thesis-defining, net-neutral-to-mixed at today’s price. The changes build genuine long-run optionality (three platforms and a credible path toward the $50B ambition) while sharply raising the near-term risk profile (leverage, dilution, integration, model drift into a soft cycle). Which way they net depends entirely on the price paid for an unproven-at-scale execution bet — and the market has voted the risk up.

9. Risk Analysis (Risk Matrix)

The dominant risks are the correlated cluster — an integration miss and a soft cycle would simultaneously dent EBITDA and strain a 5x-levered balance sheet — which is why the bear tail is fatter than a net-cash compounder’s. Catastrophic total loss is unlikely (the assets are real and strategics would pay 11–13.5x for the pieces), but a leverage-amplified 50%+ equity drawdown in a bad scenario is entirely plausible.

10. Valuation Discussion (Embedded Expectations)

GAAP multiples are meaningless here (persistent losses to common), so QXO must be valued on EV / forward combined adjusted EBITDA and on the option value of the roll-up.

Reconstructing the combined enterprise value (marked to $16.21 on 2026-07-02). From the S-4 pro-forma balance sheet (which already incorporates Kodiak and TopBuild):

• Common: ~711M existing + ~312.5M issued to TopBuild holders ≈ ~1,023M shares → market cap ~$16.6B (using the ~1.02B pro-forma common; the ~1.08B basic weighted count lifts this modestly).
• Net debt: pro-forma funded debt ~$8.96B less cash ~$0.95B = ~$8.0B.
• Preferred stack: Series C convertible perpetual (Apollo) $2.94B + Convertible Perpetual (Series A) $1.0B + Mandatory Convertible (Series B) $575M ≈ ~$4.0–4.5B (liquidation value).
• Combined EV ≈ $28–31B including all preferred (~$24.5B if the convertibles are treated as equity).

The multiple. Combined run-rate adjusted EBITDA is ~$2.0–2.2B (Beacon ~$0.95B + Kodiak ~$0.21B + TopBuild pro-forma ~$1.1B, less corporate/transformation drag), rising to ~$2.4–2.5B with the targeted $300M of synergies. That yields ~13–15x EV/EBITDA pre-synergy, ~11–12x post-synergy. Leverage is ~3.8x net (≈5.2x including the Series C), with a ~$650–750M/year cash burden of interest plus preferred dividends against ~$2.1B of EBITDA.

Peer-relative — no discount.

QXO’s combined multiple sits at the top of the pure distributors and in line with premium FERG — but with no current GAAP profit, 3.8–5.2x leverage (versus net-cash WSO/POOL), and unproven simultaneous integration. It is cheaper than the ~19–21x premium compounders, but those are proven, net-cash, high-ROIC franchises; QXO is the opposite balance sheet and track record. There is no valuation discount here — you pay a full, market-to-high multiple for the roll-up option, at roughly the blended price QXO paid for the assets.

Embedded-expectations / reverse read. At $16.21 and ~$28–31B EV, the market is emphatically not capitalizing the “$50B revenue, mid-teens margin” ambition — if it were, the stock would embed $5–7B+ of future EBITDA and trade multiples higher. The ~30–35% de-rating since the April signing prices skepticism, not euphoria: doubt on synergy capture and triple-integration, discomfort with ~5x leverage into a rate-sensitive cycle, heavy dilution, and “show-me” cash flow. In effect, the equity is fair-to-full on today’s numbers, and all the upside is the option value of Jacobs compounding EBITDA past ~$2.1B. The only margin of safety is asset value — strategics pay 11–13.5x to enter this channel, putting a floor under the pieces — not the multiple.

Scenarios (framing, ~2028–29 horizon; not a price target).

The skew is wide and leverage-amplified: the same operational miss that dents EBITDA also strains a 3.8–5.2x-levered balance sheet, so the bear tail is fatter than a net-cash compounder’s, and the bull requires two independent bets — a cycle turn and proven synergy execution.

11. Variant Perception

Consensus. The sell-side is constructive-but-fading — several Overweight/Buy ratings that lean on Jacobs’ track record and the platform vision, but with price targets being trimmed (KeyBanc $32→$28, July 2026) as the stock de-rates. The prevailing view is “great operator, transformational platform, give it time” — with the market simultaneously voting that skepticism into a 30–35% drawdown.

The strongest bull case. Brad Jacobs has done this five times and created enormous shareholder value each time, including the rare double of building and unbundling XPO. He is assembling, at speed, a leading position in a fragmented, defensively-anchored (R&R roofing), >$200B market, with ~$3B of preferred dry-powder and a credible margin-transformation toolkit (digital, private label, procurement). If the housing cycle turns and even partial synergies land, combined EBITDA compounds past $3B, the balance sheet deleverages, and a proven QXO re-rates toward the premium compounders — a multi-bagger from a de-rated $16.

The strongest bear case. You are paying a full multiple (13–15x, the top of the space) for a business with no structural moat, no current GAAP profit, deeply negative tangible equity, ~1.7B fully-diluted shares, and ~5x leverage — into a soft, rate-sensitive cycle, run by a 69-year-old key man, with the wrong incentive metric (relative TSR, no ROIC) and no open-market insider buying. The industry just absorbed >$40B of competing strategic capital (Home Depot, Lowe’s) that caps both pricing and tuck-in-multiple upside, and QXO already lost GMS to a deeper pocket. The bear tail is fat because leverage amplifies any miss.

The 3–5 assumptions that matter most:

1. Can the tech-enabled transformation actually expand combined adjusted-EBITDA margin toward the low-teens? (No QXO evidence yet; the whole quality thesis rests here.)
2. Does the housing/R&R cycle turn within the deleveraging window? (Currently soft; rates are the swing factor for both demand and the floating-rate debt.)
3. Can three platforms be integrated simultaneously without value leakage? (Unprecedented pace; no QXO integration track record.)
4. Is Jacobs disciplined on the next deal, or does he keep paying full multiples with dilutive paper? (TopBuild at 14.9x is a warning; comp rewards size.)
5. Does the capital cycle (Home Depot/Lowe’s/ABC Supply) compress returns before QXO scales its edge? (Marathon says high returns that attracted this much capital tend to mean-revert.)

Factor-positioning read (what the tape is pricing). The factor model barely fits (R² ~3–7%; idiosyncratic specific volatility ~55%) — returns are deal-driven, not factor-driven, so QXO is a genuinely idiosyncratic special situation. Beta is a deceptively-low ~0.8–0.9 (the ~55–110% realized volatility is stock-specific), with a mild SmallSize tilt and no Value and no Quality loading — the “cheap” P/B is a goodwill/shell artifact, not a value signal. The mild +0.25 raw Momentum loading is contradicted by deeply negative realized returns: every leaderboard horizon shows negative Sharpe (y1 −21.9%, m6 −38% annualized, m3 −46% annualized), relative strength is negative across the board, and the price is below its 21-, 50- and 200-day averages. The tape is a falling knife / one-way street down — a de-rated, deal-driven special situation the market is voting skeptical on, not a momentum trade and not a factor-value name. The acquirer’s own ~29% no-collar slide has already cost TopBuild holders ~$80/share of consideration — the clearest evidence that the market doubts the megadeal math. (Ignore the sector labels and related-stock lists in third-party feeds — “Oil Equipment,” “Consumer Staples,” BeiGene, China ETFs — all artifacts of the stale SilverSun software misclassification.)

12. Fact vs. Interpretation Table

13. Open Questions

1. What is Beacon’s true organic growth rate? Cannot be isolated from filings (QXO owned Beacon only ~8 months, no comparable-branch disclosure); anecdotal evidence is negative. This is the single most important unknown for the transformation thesis.
2. What is the realistic phasing of the $300M TopBuild synergies (and unquantified Beacon/Kodiak synergies) — front-loaded, or back-end to 2030? The “cheap” 11.8x depends on it.
3. How much more equity/preferred will be issued to fund the path to $50B? The charter authorization was raised to 4.0B shares — signaling continued dilution.
4. Will Jacobs maintain discipline on the next platform, or keep paying full multiples with an undervalued currency?
5. How does the combined company perform through a genuine downturn at ~5x leverage — the scenario the balance sheet has never been tested against?
6. When (and whether) does the housing/R&R cycle turn, and how sensitive is the deleveraging path to rates?

14. What Must Be True

Bull case — what must be true, and its falsification test. The tech-enabled transformation must be real and margin-accretive, the three platforms must integrate without value leakage, and the housing/R&R cycle must turn within the deleveraging window — so that combined adjusted EBITDA compounds from ~$2.1B toward $3B+, leverage falls below 3x, and a proven QXO re-rates toward premium-compounder multiples.

• Falsification test: If, over the next 3–4 quarters, combined adjusted-EBITDA margin does not expand toward the low-teens (i.e., stays stuck near current levels), organic volumes remain negative, and net leverage does not fall below ~3.5x, the bull thesis is broken — the transformation is slideware, not economics.

Bear case — what must be true, and its falsification test. QXO must be a full-multiple, no-moat, over-levered roll-up whose returns get compressed by the capital cycle and whose GAAP losses and dilution overwhelm the adjusted-EBITDA story — so the equity stagnates or de-rates further as leverage bites into a soft cycle.

• Falsification test: If QXO demonstrates two-to-three quarters of clear synergy capture (combined margin rising), organic volume inflecting positive, and deleveraging below 3x — and completes a genuinely accretive next deal at a disciplined multiple — the bear thesis is falsified: the machine works, and the de-rating was the entry point.

15. Source Appendix

See Appendix B (Source Appendix) below for the full, dated source list. Primary sources include: QXO FY2025 Form 10-K (filed 2026-02-27); QXO Q1-2026 Form 10-Q (filed 2026-05-12); the TopBuild Form S-4/A (declared effective 2026-05-29) with its unaudited pro-forma combined financials, deal terms and financing; QXO 8-Ks on the Beacon, Kodiak and TopBuild transactions and financing (2024–2026); QXO DEF 14A (compensation and PSU terms); Form 3/4/5 insider filings; public filings and disclosures of building-products peers (TopBuild/BLD, XPO, Builders FirstSource/BLDR, SiteOne/SITE, Watsco/WSO, Pool/POOL, Ferguson/FERG); ROIC.ai (statements, ratios, enterprise value); and public price/factor data. Third-party aggregated data is reconciled to filings; EDGAR and the 10-K/10-Q/S-4 are primary.

APPENDIX A — Standard Diligence Questionnaire

As-of 2026-07-02. Fact / Interpretation / Assumption labeled where it matters. QXO completed its ~$17B TopBuild acquisition ~July 1, 2026; figures are pro-forma where noted.

General

What thoughtful questions have other investors asked about this company? Chiefly: (1) Is Jacobs’ track record transferable to building-products distribution, or was XPO’s success industry-specific? (2) Is QXO paying too much (TopBuild at 14.9x at a housing trough)? (3) How dilutive is the stacked capital structure really (the answer: ~1.7B fully-diluted shares vs. 725M common)? (4) Can three platforms be integrated simultaneously? (5) Is “tech-enabled distribution” a genuine edge or table stakes against Home Depot/SRS? (6) Does ~5x leverage into a soft cycle create a fat downside tail? (Interpretation, synthesized.)

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Low. Single-family starts are ~17% below the 2021 peak; TopBuild’s Q1-2026 installation organic volume was −9.8%; Beacon volumes are down y/y. Adjusted EBITDA is depressed relative to a mid-cycle run-rate. (Fact + Interpretation.) Driven by the external environment or internal actions? Both — the external soft housing/rate environment depresses volumes; internal transformation/deal costs depress reported margins ahead of benefits. (Interpretation.) How stable are revenues? Bimodal: ~half defensive (R&R re-roofing ~80% of roofing demand, ~94% non-discretionary; TopBuild counter-cyclical distribution + code-required insulation), ~half cyclical (new-residential, non-residential, LBM). None contractually recurring. (Fact.) Outlook for products/services? Structural demand is durable (roofs and insulation are non-deferrable); near-term is soft; secular offset in data-center/industrial mechanical insulation. (Interpretation.) How big will this market be? ~$800B global building-products distribution; QXO frames its combined addressable market at “>$200B.” Growing low-to-mid single digits through cycle; fragmented, domestic-focused (~98% US). (Fact — company framing.)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More — >$40B of strategic capital entered in 2024–26 (Home Depot/SRS+GMS, Lowe’s/FBM+ADG, QXO itself). Marathon capital-cycle read: negative for forward returns. (Fact + Interpretation.) How profitable is the business (ROIC, ROE)? GAAP ROE/ROIC are meaningless (losses; deeply negative tangible common equity — goodwill+intangibles = 75% of assets). Economically, distribution adjusted-EBITDA margins ~9.5–12%, TopBuild installation ~18%; through-cycle returns on tangible capital are cyclical (peer range ~7% trough to low-30s peak). (Fact + Interpretation.) How profitable is the industry — competitors, barriers? Thin-margin, cyclical; many competitors (>7,000 NA distributors); low-to-moderate local barriers (density, supplier relationships), no national barrier. (Fact.) Can the business be easily understood? Yes at the unit level (buy from manufacturers, sell to contractors); the capital structure and pro-forma accounting are complex (three deals, three preferred series, warrants, PPA). (Interpretation.) Can it be undermined by foreign low-cost labor? No — local, service-and-logistics-intensive distribution/installation; not offshorable. (Fact.) Do brands matter? Manufacturer brands matter to contractors (Owens Corning, GAF); the distributor brand does not create lock-in. TRI-BUILT private label is a margin lever, not a moat. (Interpretation.) Nature of competition? Local density, fill rate, delivery reliability, credit, price. (Fact.) Customers’ switching costs? Moderate — most contractors multi-source and can re-source; relationships and convenience create stickiness, not lock-in. (Interpretation.)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The branch networks/customer relationships are largely capitalized as PPA intangibles ($10.9B) + goodwill ($15.3B); the real asset (local relationships, crews) is partly intangible. Strategic-bid comps (11–13.5x) imply the pieces are worth more than book in a sale. (Interpretation.) Off-balance-sheet liabilities? Operating leases (branches/DCs) are on-balance-sheet under ASC 842; the ~$2.94B Series C sits in mezzanine (temporary) equity, not debt — economically debt-like. (Fact + Interpretation.) How conservative is the accounting? GAAP is conservative-to-punitive (heavy PPA amortization, inventory step-ups depress earnings); the adjusted presentation is aggressive in parts (recurring deal/transformation costs and SBC added back). (Interpretation.) How CapEx-hungry? Light — distribution capex is modest; TopBuild installation is asset-light (~1.1% of sales). FY2025 capex ~$74M on $6.84B sales. (Fact.)

Capital Allocation & Management

How much FCF, and how is it used? FY2025 true FCF ~$190M (OCF $261.4M − ~$74M capex), scaling with the platform; ROIC’s reported “$261M FCF” omits capex. All internally-generated cash and raised capital goes to M&A — no buybacks, no dividend. (Fact.) Significant acquisitions recently? Three in ~15 months: Beacon (~$10.79B, Apr-2025), Kodiak (~$2.25B, Apr-2026), TopBuild (~$17B, Jul-2026) — ~$30B deployed. (Fact.) Buying back shares? No. Issuing shares to insiders? Structurally: Jacobs Private Equity II holds ~$1B of Convertible Perpetual Preferred (~197M as-converted at $4.566) plus warrants; escalating equity raises ($9.14→$23.80); charter authorization raised to 4.0B shares. Heavy net issuance. (Fact.) Compensation policy? Executive PSUs vest on relative TSR vs. the S&P 500 — no ROIC/return metric; Jacobs’ initial PSUs certified at 225% of target (max) through Dec-2025. A Marathon-style demerit (rewards size/index-beating, not economic return). (Fact + Interpretation.) Motivations of management? Genuine structural alignment (Jacobs ~$1B at-risk preferred) — but zero open-market (code-P) insider buys in the QXO era; the incentive metric rewards growth over returns. (Fact.)

Valuation & Market Data

ADR, MLP, or K-1? None — a Delaware C-corp; standard 1099 common stock (plus QXO.PRB depositary preferred shares). (Fact.) Dividend policy? No common dividend. Preferred pays cash coupons (Convertible Perpetual 9%; Mandatory Convertible 5.50%; Series C ~4.84%). (Fact.) How profitable is the business? Adjusted EBITDA ~$2.0–2.2B (~11–12% margin) pro-forma; GAAP net loss to common −$851M even normalized. (Fact.) Is net income diverging from cash from operations? Yes, structurally — GAAP net income is far below OCF because of ~$1.22B of non-cash PPA amortization; but OCF itself is modest (~$261M FY2025) and heavily seasonal. (Fact.)

Risks & Downside

What would cause the stock to decline? A deepening housing/R&R downturn, synergy/integration shortfall, higher-for-longer rates (demand + floating debt), a botched or richly-priced next deal, or further dilution — all amplified by ~5x leverage. (Interpretation.) Risk of a catastrophic loss? A leverage-amplified 50%+ drawdown is plausible in a bad cycle-plus-integration scenario. (Interpretation.) Chance of a total loss? Low — the asset base is real and strategics would pay 11–13.5x for the pieces, flooring the enterprise value; but the equity sits behind ~$8B net debt + ~$4B preferred, so a severe downturn could impair it substantially. (Interpretation.)

Recent News & Events

Has the business environment changed recently? Yes, transformationally — the company is the change (Jacobs takeover Dec-2023 → three platforms by Jul-2026). Near-term: soft end markets; sell-side de-rating (KeyBanc $32→$28). (Fact.) Significant acquisitions? TopBuild closed ~July 1, 2026 — the defining recent event. (Fact.) Change in accounting policies? No policy change; heavy purchase accounting (PPA amortization, inventory step-ups) from the acquisitions dominates the optics. (Fact.) Recent changes — new markets, facilities, management? New into insulation installation (TopBuild) and LBM (Kodiak); ex-XPO/URI executives staffed in; new insiders onboarded post-close (July 2026 Form 3/4). (Fact.)

APPENDIX B — Source Appendix

Report date 2026-07-02. Primary sources before secondary; every non-obvious fact traces here. Third-party aggregated data (ROIC.ai, public factor and price data) is reconciled to filings; EDGAR and the 10-K/10-Q/S-4 are primary.

Primary — SEC filings (QXO, CIK 0001236275; note: pre-2024 filings are the legacy SilverSun Technologies shell and are NOT used for the thesis)

1. QXO FY2025 Form 10-K — filed 2026-02-27 (qxo-20251231.htm). Item 1 business/products/suppliers; MD&A non-GAAP reconciliation (Adjusted Gross Profit/EBITDA/EPS, pp. 26–28); Note 6 Equity (Convertible Perpetual Preferred, Mandatory Convertible, warrants); debt (Senior Secured Notes, Term Loan, ABL); Beacon purchase accounting; segment/line-of-business revenue; “dependence on Brad Jacobs” and “past performance may not be representative” risk factors. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001236275
2. QXO Q1-2026 Form 10-Q — filed 2026-05-12 (qxo-20260331.htm). Q1 balance sheet (cash $3,046M; goodwill $5,129M; intangibles $3,704M; shares 710.8M); Q1 net loss −$227M; line-of-business mix.
3. TopBuild Form S-4 / S-4/A — filed 2026-05-18 / effective 2026-05-29 (tm2612250). Deal terms ($505/sh, 45% cash / 55% stock at 20.200x, no collar, $600M break fee); Unaudited Pro Forma Condensed Combined Financial Statements (balance sheet & income statement incl. Kodiak + TopBuild; net sales $17,283.7M; net loss to common −$851.2M; goodwill $15,312.7M; intangibles $10,904.5M; pro-forma debt & Note 6; Note 8 antidilutive/EPS with 621M overhang); financing (new $3.0B term loan + $3.0B notes; Series C).
4. QXO 8-K, TopBuild completion — filed 2026-07-01 (tm2618991d7_8k.htm). Completion of TopBuild acquisition; Term Loan Facility Amendment (Goldman Sachs-led); securities (common QXO; QXO.PRB 5.50% Series B Mandatory Convertible depositary shares).
5. QXO 8-Ks / 425s (2024–2026) — Beacon tender & completion (Apr-2025); Kodiak (announced Feb-2026, closed Apr-1-2026); TopBuild announcement (2026-04-19/20); financing (Series C preferred; senior notes; term loans); shareholder-vote results (2026-06-29).
6. QXO DEF 14A (proxy) — executive compensation; PSU vesting on relative TSR vs. S&P 500 (no ROIC metric); Jacobs initial-period PSU certification at 225% of target; 2024 Omnibus Plan share limits; charter share-authorization increase to 4.0B.
7. QXO Form 3/4/5 (insider filings) — Jacobs and directors/officers; codes A/M/F/S (grants, option exercises, tax withholding, sales); no code-P open-market purchases in the QXO era; new insider Form 3/4 filings dated 2026-07-01/02 post-TopBuild.

Primary — earnings calls / company communications

8. TopBuild Q4-2025 earnings call — 2026-02-26 (via ROIC.ai). FY2025 revenue >$5.4B / adjusted EBITDA ~$1.04B (~19% margin); 2030 Investor-Day targets reaffirmed; FY2026 guidance assuming no cycle recovery; ~$95B TAM framing.
9. Beacon Roofing Q4/FY-2024 earnings call — 2026-02-27 (labeled “QXO Q4-24” in ROIC; actually Beacon). Beacon FY2024 ~$9.8B sales / >$930M adjusted EBITDA; organic volume −3–4%/day; QXO tender chronology.
10. QXO Q1-2026 press release — 2026-05-12 (BusinessWire). Net sales $1,730M; net loss −$227M; adjusted EBITDA $1.2M; Jacobs “$50 billion in annual revenue within a decade” reaffirmation.
11. QXO / TopBuild deal press releases — “QXO to Acquire TopBuild for $17 Billion” (2026-04-20); stockholder-approval and completion releases (2026-06-29 / 2026-07-01), investors.qxo.com.

Secondary — industry, transactions, trade press

12. Home Depot / SRS Distribution & GMS — CNBC, “Home Depot’s SRS buys GMS,” 2025-06-30 (channel capital-cycle; QXO lost GMS). https://www.cnbc.com/2025/06/30/home-depot-srs-distribution-buys-gms.html
13. QXO / Kodiak — Reuters/Investing.com, “Jacobs’ QXO to buy Kodiak for $2.25 billion,” Feb-2026; HousingWire, “QXO closes on Kodiak Building Partners deal,” Apr-2026.
14. KeyBanc price-target revision — QXO $32→$28, 2026-07-01 (trade press).
15. U.S. single-family housing starts — U.S. Census / NAHB (~941k SF starts 2025, ~17% below 2021 peak) — flagged for independent primary verification.

Quantitative data providers (reconciled to filings)

16. ROIC.ai MCP — income statement, balance sheet, cash flow, per-share and enterprise-value data (multi-period); used for cross-check, reconciled to the 10-K/10-Q/S-4.
17. Market data feeds — a news feed (~19 QXO articles) and valuation-index own-history percentiles (composite 39.1; P/B 1.21x/18th pctile — flagged as goodwill-inflated and low-signal); daily price CSV (used for the five-year event map; unadjusted = real traded price).
18. FactorsToday — factor loadings (R² ~3–7%, barely fits), leaderboard (negative Sharpe every horizon), stock-info (beta ~0.9, negative relative strength, below all EMAs). Sector labels/related-stocks flagged as stale-SilverSun artifacts and disregarded.

Peer / cross-read references (public)

19. TopBuild Corp. (BLD) — FY2025 Form 10-K and Q4-2025 earnings materials — standalone TopBuild economics and deal mechanics.
20. XPO, Builders FirstSource (BLDR), SiteOne (SITE), Watsco (WSO), Pool (POOL), Ferguson (FERG) — public filings for Jacobs track-record framing (XPO) and building-products peer comps and industry structure.